EUVIMEDEUVIMED entdecken
Crossref

Feasibility, accuracy, and usability analysis of MapAML , a first‐in‐class app for integrated diagnosis in acute myeloid leukemia

Thaís B Moyen iD, Victoria Tomaz, Paulo V Campregher

European Journal of Haematology · 2024

DOI: 10.1111/ejh.14158 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Haematology, 2024. Verfasst von Thaís B Moyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein (Rua Rubens do Amaral), São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Mobile Applications, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Performing a comprehensive diagnosis of acute myeloid leukemia (AML) is complex and involves the integration of clinical information, bone marrow morphology, immunophenotyping, cytogenetic, and molecular analysis, which can be challenging to the general hematologist. The aim of this study was to evaluate the usability and accuracy of MapAML, a smartphone app for integrated diagnosis in AML, created to aid the hematologist in its clinical practice. App performance was evaluated in dedicated sessions, in which 21 hematologists or fellows in hematology performed an integrated diagnosis of deidentified real‐world clinical AML cases, first without and posteriorly with MapAML use. Diagnosis accuracy increased after MapAML utilization, with the average score going from 7.08 without app to 8.88 with app use (on a scale from 0 to 10), representing a significant accuracy improvement ( p = .002). Usability evaluation was very favorable, with 81% of users considering the app very or extremely simple to use. There was also a significant increase in confidence to perform a complete and accurate diagnosis in AML after app use, with 61.9% of the participants willing to use the app in their clinical practice. In this study, MapAML increased accuracy with excellent usability for integrated diagnosis in AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mobile ApplicationsLeukemia, Myeloid, AcuteHumansFeasibility StudiesCytogeneticsImmunophenotyping

Stichwörter der Autor:innen

diagnosishematologyleukemia, myeloid, acutemedical informatics applicationsmobile applications

Autor:innen und Institutionen

  • Faculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein (Rua Rubens do Amaral), São Paulo, São Paulo, Brazil.
  • Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil.

ORCID-Profile: Thaís B Moyen

Zitieren

APA

Moyen, T. B., Tomaz, V., & Campregher, P. V. (2024). Feasibility, accuracy, and usability analysis of MapAML , a first‐in‐class app for integrated diagnosis in acute myeloid leukemia. European Journal of Haematology. https://doi.org/10.1111/ejh.14158

Vancouver

Moyen TB, Tomaz V, Campregher PV. Feasibility, accuracy, and usability analysis of MapAML , a first‐in‐class app for integrated diagnosis in acute myeloid leukemia. European Journal of Haematology. 2024. doi:10.1111/ejh.14158

BibTeX
@article{Moyen2024,
  author = {Moyen, Thaís B and Tomaz, Victoria and Campregher, Paulo V},
  title = {Feasibility, accuracy, and usability analysis of MapAML , a first‐in‐class app for integrated diagnosis in acute myeloid leukemia},
  journal = {European Journal of Haematology},
  year = {2024},
  doi = {10.1111/ejh.14158}
}
Kostenlos starten →